FDA Adverse Event Malfunction Summary report: N

ACHIEVE MAPPING CATHETER

MDR report key: 7237496 · Received February 2, 2018

Report

Report Number
9612164-2018-00194
Event Type
Malfunction
Date Received
February 2, 2018
Date of Event
September 29, 2017
Report Date
February 2, 2018
Manufacturer
MEDTRONIC MEXICO
Product Code
DRF
PMA / PMN Number
K102588
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

EVENT SUMMARY: THE PATIENT DATA FILES SHOWED FOUR INJECTIONS WERE PERFORMED WITH CATHETER 2AF283/12131-21 WITHOUT ANY ISSUES OR SYSTEM NOTICES. UPON VISUAL INSPECTION OF ACHIEVE MAPPING CATHETER 990063-020 / 213478292, RESULTS SHOWED THE LOOP ARRAY WAS DAMAGED AND A KNOT WAS OBSERVED 0.62IN FROM THE TIP. FURTHERMORE, THE CATHETER SHAFT WAS BROKEN 11 INCHES FROM THE TIP. ADDITIONAL INSPECTION UNDER MICROSCOPE DID NOT REVEALED ANY KINK ON PEBAX SHAFT. THE REPORTED ISSUE DOES NOT INDICATE A MAPPING CATHETER¿S MANUFACTURING RELATED DEFECT. IN CONCLUSION, THE REPORTED ISSUE (ACHIEVE TIP DAMAGE/BROKEN) WAS CONFIRMED THROUGH TESTING. THE MAPPING CATHETER FAILED THE RETURNED PRODUCT INSPECTION DUE TO A DAMAGED TIP/LOOP SECTION AND BROKEN SHAFT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A CRYO ABLATION PROCEDURE, THE TIP OF THE MAPPING CATHETER BROKE WHEN IT WAS PULLED BACK INTO THE SHEATH FOR ADDITIONAL ABLATION. THE BROKEN END OF CATHETER WERE SUCCESSFULLY REMOVED WITH THE SHEATH, AS CONFIRMED VIA XRAY. THE CASE WAS COMPLETED WITH CRYO. THE MAPPING CATHETER WAS RETURNED TO THE MANUFACTURER, ANALYZED, AND TESTED OUT OF SPECIFICATION. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
82030 ACHIEVE MAPPING CATHETER CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING DRF MEDTRONIC MEXICO 990063-020 213478292

Patients

Seq Age Sex Outcome Treatment
1 34 YR